Full Length Research Paper
References
|
Adigun AQ, Ishola DA, Akintomide AO, Ajayi AAL (2003). Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. J. Hum. Hyper. 17:277-85. crossref |
||||
| Aguwa CN (2004). Hypertension In: Aguwa CN (ed): Therapeutic basis of Clinical Pharmacy in the tropics. 3rd edn. Enugu: Optimal Publishers. pp. 102-139. | ||||
| Akinkugbe OO (2002). Current epidemiology of hypertension in Nigeria. Arch. Ibadan Med. 1:3-5. | ||||
|
Anderson GH (1999). Effect of age on hypertension: Analysis of over 4, 800 referred hypertensive patients. Saudi J. Kid Trans. 10(3):286-297. crossref |
||||
|
Angeli F, Reboldi G, Verdecchia P (2014). Hypertension, inflammation and atrial fibrillation. J. Hyperten. 32:480. crossref |
||||
| Augustine L, Prasanth NV, Sanal Dev KT, Jasmin S, Kappekkat Y, Shinu C, Thayyil A (2010). A study conducted on prescribing pattern and cost of antihypertensive drugs in a tertiary level hospital in South Malabar region of Kerala. Der. Pharma Chemica. 2(6):332-341. | ||||
| Bajaj JK, Sood M, Singh SJ, Jerath P (2012). Prescription patterns of antihypertensive drugs and adherence to JNC VII guidelines in a tertiary care hospital in North India. Int. J. med. Clin. Res. 3(2):118-120. | ||||
| Benowitz NL (2007). Cardiovascular/Renal drugs-Antihypertensive agents In: Katzung BG, editor: Basic and Clinical Pharmacology. 10th edn. McGraw Hill company Inc. pp. 159-181. | ||||
|
Chobanian AV, Bakris GL, Black HR, (2003). National High Blood Pressure Education Program Coordinating Committee. Seventh Report of The Joint National Committee On Prevention, Detection, Evaluation, and Treatment Of High Blood Pressure. The JNC 7 Report. JAMA.; 289:2560–2572. crossref |
||||
|
Chou C, Lee M, Ke C, Chung M (2004). Prescription pattern of hypertension – National Insurance in Taiwan. J. Chin. Med. Assoc. 67:123-130. |
||||
|
Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA (1990). Blood pressure, stroke, and coronary heart disease. Part 2: Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 335:827-838. crossref |
||||
| Edward PR, Lunt DW, Fehrsen GS, Lombard CJ, Steyn K (1998). Improving cost-effectiveness of hypertension management at a community health center. South Africa. S Afr. Med. J. 88:549-54. | ||||
|
Fadayomi MO, Akinroye KK, Ajao RO, Awosika LA (1986). Monotherapy with nifedipine for essential hypertension in adult blacks. J. Cardiovasc. Pharmacol. 8(3):466-469. crossref |
||||
|
Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm RH Jr, Hall WD, Jones WE, Kountz DS, Lea JP, Nasser S, Nesbitt SD, Saunders E, Scisney-Matlock M, Jamerson KA (2010). Management of high blood pressure in blacks: an update of the International Society on Hypertension in blacks consensus statement. Hypertension 56(5):780-800. crossref |
||||
|
Ford GA, Asghar MN (1995). Management of hypertension in the elderly: attitudes of general practitioners and hospital physicians. Br. J. Clin. Pharmacol. 39(5):465-469. crossref |
||||
|
Fuentes R, Ilmaniemi N, Laurikainen E, Tuomilehto J, Nissinen A (2000). Hypertension in developing economies: a review of population-based studies carried out from 1980 to 1998. J. Hypertens 18:521–529. crossref |
||||
|
Gavras I, Rosenthal T (2004). Combination therapy as first-line treatment for hypertension. Curr Hypertens Rep. 6:267-272. crossref |
||||
|
Godley P, Pham H, Rohack J, Woodward B, Yokoyama K, Maue SK (2001). Opportunities for improving the quality of hypertension care in a managed care setting. Am. J. Health Syst. Pharm. 58:1728-1733. |
||||
|
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR1, Wright JT Jr, Narva AS, Ortiz E (2014). Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eight Joint National Committee (JNC 8). JAMA. 311(5):507-520. crossref |
||||
|
Kadiri S, Walker O, Salako BL, Akinkugbe OO (1999). Blood Pressure, Hypertension and Correlates in Urbanized Workers in Ibadan, Nigeria–a revisit. J. Hum. Hypertens 13:23-27. crossref |
||||
|
Klungel OH, dE Boer A, Paes AH, Seidell JC, Nagelkerke NJ, Bakker A (1998). Under treatment of hypertension in a population based study in the Nethehlands. J. Hypertens 16:1371-1378. crossref |
||||
|
Mclnnis NH, Fodor G, Lum-kwong MM, Leenen FH (2008). Antihypertensive medication use and BP control. A community based cross sectional survey (on BP). Am. J. Hypertens 21(11):1210-1215. crossref |
||||
| FMOH (1997). Non-communicable Diseases in Nigeria. Final Report of the National Survey. Federal Ministry of Health National Expert Committee on Non-Communicable Diseases. | ||||
| Heart Disease and Pervention Program (2003). Population with Highest Burden of High Blood Pressure in Missouri 2003. http://www.dhss.mo.gov/living/healthcondiseases/ch ronic/heartdisease/index.php http://www.dhss.mo.gov/living/healthcondiseases/ch ronic/stroke/index.php | ||||
| Sandozi T, Emani VK (2010). Survey of prescription pattern of antihypertensive drugs in hypertension and hypertension associated diabetes. Inter. J. Pharm. BioL. Sci. 1(4):23-26. | ||||
| Seseen JJ (2009). Essential hypertension In: Koda-Kimble MA, Young LY, Alldredge BK, Corelli RL, Guglielino BJ, Kradjan WA, Williams BR, editors: Applied therapeutics. The clinical use of drugs. 9th Ed. New York: Lippincott Willams and Wilkins pp. 13-1-41. | ||||
| Suheela SH, Narendranth S, Somashekhar HS, Reshma SR, Keerthi SJ, Ramachandra K (2011). Prescriptive pattern of antihypertensives in a tertiary care hospital using DU-90%. Inter. J. Pharm. Res. Dev. 4(1):107-113. | ||||
|
ALLHAT Collaborative Research Group (2002). Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA; 288:2981–2997. crossref |
||||
|
Trillings JS, Froom J (2000). The urgent need to improve hypertension care. Arch. Fam. Med. 9:794-801. crossref |
||||
|
Ukwe CV, Ubaka CM (2012). Antihypertensive drug prescribing in a tertiary hospital inEastern Nigeria. Trop. J. Pharm. Res. 11(2):297-305. crossref |
||||
|
Wallenius S, Kumpusala H, Parnanen TJ (1988). Drug treatment for hypertension in Finnish primary health care. Eur. J. Clin. Pharmacol. 54:793-9. crossref |
||||
|
World Health Organisation (WHO) (2003). International Society of Hypertension (ISH) statement on management of hypertension. J. Hypertens 21:1983-1992. |
||||
| World Health Organisation (2002). The World Health Report: Risks to Health 2002. Geneva: World Health Organisation. | ||||
|
Yusuff KB, Balogun OB (2005). Physicians' prescribing of antihypertensive combinations in a tertiary care setting in southwestern Nigeria. J. Pharm. Pharm. Sci. 8:235-242. |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
